Funding for this research was provided by:
Received: 27 September 2017
Accepted: 22 August 2018
First Online: 28 August 2018
Ethics approval and consent to participate
: The study was approved by the Regional Ethics Review Board in Gothenburg, Sweden (No. 930–12), the Danish Data Protection Agency and the National Committee on Health Research Ethics in Denmark (No. 48205). The Declaration of Helsinki [ CitationRef removed ] was followed and the interviewees were informed about the study and that confidentiality was guaranteed. Information and written consent for this sub-study and INFECT were given at the acute stage of illness and obtained concurrently to reduce the strain on patients and/or next of kin acting as proxy for the patient.
: Written and oral consent has been obtained from all participant.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.